Search In this Thesis
   Search In this Thesis  
العنوان
Synthesis and characterization of chitosan nanoparticles from locust schistoserca gregaria and other sources and its efficiency as drug delivery system for ciprofloxacin /
الناشر
Narguess Hossam Eldin Marei Hussein ,
المؤلف
Narguess Hossam Eldin Marei Hussein
هيئة الاعداد
باحث / Narguess Hossam El Din Marei
مشرف / Ahmed Helmy Elwahy
مشرف / Emtithal Ali Mohamed Abd El-Samiee
مشرف / Taher Salah El Din Ali
تاريخ النشر
2014
عدد الصفحات
93 P. :
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
Chemistry (miscellaneous)
تاريخ الإجازة
1/1/2014
مكان الإجازة
جامعة القاهرة - كلية العلوم - Biotechnology
الفهرس
Only 14 pages are availabe for public view

from 114

from 114

Abstract

Chitosan is a biodegradable biocompatible polymer derived from natural renewable resources. Chitosan has a primary amino group which gives it a cationic character. These primary amino groups are responsible for numerous applications in various fields such as: in situ gelation, efflux pump inhibitory properties, mucoadhesion, permeation enhancement, and transfection and as a drug delivery system. Chitosan Nanoparticles (CSNPs) are used as vectors in nanoparticles drug delivery systems (NDDS). They provide targeted, sustained release and biodegradability. In this study chitosan from different sources was used to prepare ciprofloxacin (a wide range antibiotic from the quinolones family) chitosan based nanoparticles by ionic gelation method. The CSNPs were characterized using Fourier transform infrared (FTIR) spectroscopy, zeta sizer and scanning electron microscope (SEM). The release kinetics of the ciprofloxacin incorporated CSNPs showed sustained release of the ciprofloxacin. This formulation was tested for antimicrobial activity against a wide range of bacterial strains. The results showed antibacterial activity against gram positive bacteria (methicillin - resistant staphylococcus aureus (MRSA), bacillus subtilis) with minimum inhibitory concentration (MIC) varied from 0.03 to 2.17 æg/ml and from 0.0043 to 2.17 æg / ml MIC against gram negative bacteria escherichia coli E.coli, pseudomonas aeruginosa